Ewha Med J.  1981 Sep;4(3):129-138. 10.12771/emj.1981.4.3.129.

The Effect of Tranquilizer on 3-Hydroxy-3-Methylglutaryl-CoA Reductase of Liver and Brain Tissue of Rats

Affiliations
  • 1Department of Neuropsychiatry, College of Medicine, Ewha Womans University, Korea.

Abstract

The incidence of mental illness in the modern society has been increasing and the use of the tranquilizer for the treatment of these illnesses has been increasing also. The side effects of the tranquilizer are reportedly, minimal and the long term use of the medicine is widely practised in this field. But the question of its effect on cardiovascular system has been discussed previously and the level of cholesterol and triglyceride was found to increase in patients who have been on the tranquilizer for a long period of time. The current study was undertaken to find out the effect of tranquilizer(chlorpromazine, thioridazine, perphenazine, haloperidol, and pimozide) given to the animals for 4 weeks. And the results are summarized as follow: 1) In the animal group given chlorpromazine, thioridazine, and perphenazine, the level of total serum cholesterol was increased and the activity of microsomal HMG-Co A reductase was also increased. However, in the group given haloperidol and pimozide, there was no increase of cholesterol level or activity of microsomal HMG-Co A reductase. 2) The correlation of serum total cholesterol level and the activity of HMG-Co A reductase in the liver and brain was significant. From the Above results, it could be concluded that the effect of the long term use of tranquilizer on the cadiovascular systerm should be reevaluated.


MeSH Terms

Animals
Brain*
Cardiovascular System
Chlorpromazine
Cholesterol
Haloperidol
Humans
Incidence
Liver*
Oxidoreductases*
Perphenazine
Pimozide
Rats*
Thioridazine
Triglycerides
Chlorpromazine
Cholesterol
Haloperidol
Oxidoreductases
Perphenazine
Pimozide
Thioridazine
Full Text Links
  • EMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr